Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPROVE-IT trial of Vytorin versus simvastatin after acute coronary syndrome
2005-001059-39Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute coronary syndrome (ACS), hyperlipidemia and familial hyperlipidemia comparing Inegy arm with Zocor arm (2 arms). Primary endpoints: Primary efficacy endpoint and Composite clinical benefit endpoint. Started Sep 2005; status: completed.
02
Drugs
ezetimibesimvastatin
03
Conditions
acute coronary syndrome (ACS)hyperlipidemiafamilial hyperlipidemia
Beyond the preview
Go deeper on 2005-001059-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001059-39.